Retargeting Phages from Bacteria to Human Cells

Overview

Journal J Med Life

Specialty General Medicine

Date 2024 Nov 14

PMID 39539430

Authors

Sergiu Chira

Stefan Strilciuc

Dafin Fior Muresanu

Affiliations

Soon will be listed here.

References

Tamura R, Toda M . Historic Overview of Genetic Engineering Technologies for Human Gene Therapy. Neurol Med Chir (Tokyo). 2020; 60(10):483-491. PMC: 7555159. DOI: 10.2176/nmc.ra.2020-0049. View

Choi D, Jin H, Yoo S, Lee S . Cyclic RGD peptide incorporation on phage major coat proteins for improved internalization by HeLa cells. Bioconjug Chem. 2013; 25(2):216-23. DOI: 10.1021/bc4003234. View

Staquicini F, Smith T, Tang F, Gelovani J, Giordano R, Libutti S . Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies. Cancer Gene Ther. 2019; 27(5):301-310. PMC: 6879804. DOI: 10.1038/s41417-019-0101-2. View

Hajitou A, Rangel R, Trepel M, Soghomonyan S, Gelovani J, Alauddin M . Design and construction of targeted AAVP vectors for mammalian cell transduction. Nat Protoc. 2007; 2(3):523-31. DOI: 10.1038/nprot.2007.51. View

Mitra A, Barua A, Huang L, Ganguly S, Feng Q, He B . From bench to bedside: the history and progress of CAR T cell therapy. Front Immunol. 2023; 14:1188049. PMC: 10225594. DOI: 10.3389/fimmu.2023.1188049. View

Jaroszewicz W, Morcinek-Orlowska J, Pierzynowska K, Gaffke L, Wegrzyn G . Phage display and other peptide display technologies. FEMS Microbiol Rev. 2021; 46(2). DOI: 10.1093/femsre/fuab052. View

Hajitou A, Trepel M, Lilley C, Soghomonyan S, Alauddin M, Marini 3rd F . A hybrid vector for ligand-directed tumor targeting and molecular imaging. Cell. 2006; 125(2):385-98. DOI: 10.1016/j.cell.2006.02.042. View

Ma C, Wang Z, Xu T, He Z, Wei Y . The approved gene therapy drugs worldwide: from 1998 to 2019. Biotechnol Adv. 2019; 40:107502. DOI: 10.1016/j.biotechadv.2019.107502. View

Lombard M, Pastoret P, Moulin A . A brief history of vaccines and vaccination. Rev Sci Tech. 2007; 26(1):29-48. DOI: 10.20506/rst.26.1.1724. View

10.

Shahryari A, Jazi M, Mohammadi S, Nikoo H, Nazari Z, Hosseini E . Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders. Front Genet. 2019; 10:868. PMC: 6773888. DOI: 10.3389/fgene.2019.00868. View

11.

Gould K . Antibiotics: from prehistory to the present day. J Antimicrob Chemother. 2016; 71(3):572-5. DOI: 10.1093/jac/dkv484. View

12.

Kao C, Pan Y, Hsiao Y, Lim S, Cheng T, Huang S . Improvement of Gene Delivery by Minimal Bacteriophage Particles. ACS Nano. 2023; 17(15):14532-14544. DOI: 10.1021/acsnano.3c01295. View

13.

Chira S, Jackson C, Oprea I, Ozturk F, Pepper M, Diaconu I . Progresses towards safe and efficient gene therapy vectors. Oncotarget. 2015; 6(31):30675-703. PMC: 4741561. DOI: 10.18632/oncotarget.5169. View

14.

Iannolo G, Minenkova O, Petruzzelli R, Cesareni G . Modifying filamentous phage capsid: limits in the size of the major capsid protein. J Mol Biol. 1995; 248(4):835-44. DOI: 10.1006/jmbi.1995.0264. View

15.

Suwan K, Yata T, Waramit S, Przystal J, Stoneham C, Bentayebi K . Next-generation of targeted AAVP vectors for systemic transgene delivery against cancer. Proc Natl Acad Sci U S A. 2019; 116(37):18571-18577. PMC: 6744886. DOI: 10.1073/pnas.1906653116. View